Abiopharma

🔍 Hughes Catherine (Director)

Company: Valaris Ltd (VAL)

Report Date: 2026-06-10

Detailed Transactions and Holdings:

• Acquired 2,493 shares of Common Shares (Direct)
  Date: 2026-06-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 15,845.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 397 shares of Common Shares at $88.98 per share (Direct)
  Date: 2026-06-10 | Code: F | equity_swap_involved: 0 | shares_owned_after: 15,448.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Consists of 2,493 restricted stock units, representing the recipient's annual equity retainer, which will vest in full on the earlier of the first anniversary of the date of grant or the next annual meeting of the Company's shareholders.
• F2: These shares were withheld upon settlement or vesting to enable the reporting person to satisfy tax withholding obligations that arose upon such settlement or vesting, which will be paid by the issuer to the appropriate taxing authority in cash.